Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.

Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34186021

about

Epithelial to Mesenchymal Transition in a Clinical Perspective MicroRNA-204 suppressed proliferation and motility capacity of human hepatocellular carcinoma via directly targeting zinc finger E-box binding homeobox 2.Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis.Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition.Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2.OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer.ZEB2 inhibits HBV transcription and replication by targeting its core promoter.Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma Expression and clinical significance of PcG-associated protein RYBP in hepatocellular carcinoma.EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2.Overexpression of EMT-inducing transcription factors as a potential poor prognostic factor for hepatocellular carcinoma in Asian populations: A meta-analysis.miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells.Glyoxylate reductase/hydroxypyruvate reductase: a novel prognostic marker for hepatocellular carcinoma patients after curative resection.MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2.microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.

P2860

Q26783554-18842823-ED23-48D3-A6EE-A15BA253B02E Q33685185-104B7A4F-5512-4AEC-953E-A85A301946C6 Q33761782-E11B7467-7398-40C5-999C-BA04EB032E57 Q33802688-B6FF16FE-09D5-4CED-A17A-C6DD110AD09B Q34712612-74C96E70-C60A-458D-BAFE-AC3DBDABA437 Q35051878-F1FD7D12-8D76-4F9E-AD67-E61B29ABBD73 Q35120258-D07FC10F-A5D1-40EA-891A-11666D7F498B Q35154448-9BCC9A8C-957F-417B-90CB-5ED35FEEA7F4 Q37085933-1E2FF7F6-4EBC-4050-BD92-E560520BD60E Q37306012-F06EDFF8-0535-4ADC-8E0E-016F13AEB601 Q37594051-20DBCF21-C1F8-4604-A4B8-5F4F10D834F2 Q38040369-6D7D7FD7-4D25-4FAF-BF47-C3DBAAE07614 Q38740059-A694B66C-6040-4F75-B54E-6B12380544F1 Q38994908-E19B98B8-F93E-43DD-8979-5C72C9ACBD10 Q41709162-3E530B13-3943-4B7C-B22B-53469582CC43 Q42700949-D26C3DC6-A9E7-46E4-86E4-75A3DD593C5C Q45384144-17FE6A75-B048-48D3-BD7B-DF548A76F5F1 Q49670720-24FF5B20-3245-4B97-A149-E2818D50DCE5 Q52946388-69FDC81A-603C-477D-BBE7-9307BE3BFE8F

P2860

Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34186021

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@ast

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@en

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@nl

type

label

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@ast

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@en

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@nl

prefLabel

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@ast

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@en

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@nl

P1433

Q34186021-9EDA43F9-AEA1-43A5-9D36-D6346CB8423F

P1476

Q34186021-AB558F21-E366-4753-A725-D302444B99FD

P2093

Q34186021-0F4E69B8-6918-4C54-BF0A-92A0E3097BA5

Q34186021-2421D367-EB4A-45B8-9F8F-37EB2FDD6F99

Q34186021-2D71BA66-B85E-484B-8A9D-59C0DFD37FA5

Q34186021-2F2C1C88-12DC-4ABC-960D-E5200709230B

Q34186021-7D8F9FD0-4D48-472B-A78A-8E7488BB9A6F

Q34186021-8980DA5F-ADBC-4CE4-9609-48B027B0B4D9

Q34186021-9B5E0010-54CA-4931-9382-8AC8A7F4EC05

P2860

Q34186021-034AB4C4-2118-4DD9-BFE7-A1B1FAB86E54

Q34186021-11773B2E-4FC4-49AA-A7FD-5D716BA3759C

Q34186021-1CC80278-73C7-4599-BBC4-9EE392C688C8

Q34186021-20661F03-2B00-4800-B3A6-6D80640F8E1E

Q34186021-330BB80B-94BF-442E-B83E-17BCE8C11D58

Q34186021-34D7089F-AD83-4233-B01D-140FD6E6D2B5

Q34186021-3A202714-1790-4325-843F-0B2E32B8DCBA

Q34186021-4021CEFC-EBD8-4661-9A36-AE9D9FBE5821

Q34186021-4A47B94F-D949-41C1-A05F-8F5A8189CA1C

Q34186021-5050C597-D62A-4449-86D5-F66395F05E44

P304

Q34186021-AD393FFA-BAF4-4092-BF93-754DFEED3531

P31

Q34186021-9820FB4C-62B8-465F-BEF3-E2FA5DB76408

P356

Q34186021-7A3E8D4B-9EE5-487E-92DF-6560E17E8209

P407

Q34186021-A6DA5CBE-AAEB-4467-A41B-58C04643C56D

P433

Q34186021-983555F1-301C-463C-8A1D-BBB8AF1A6B46

P478

Q34186021-4B7DA619-8E5A-4C39-9F8E-AD5677798DA8

P577

Q34186021-B11EC4F7-7CFD-461A-B39D-F42DC9AE51D1

P5875

Q34186021-0C6BD9AD-E824-4F97-AE38-DD17872BEB97

P698

Q34186021-4070C3CE-C56C-4A09-B6E5-86B163FED5A3

P921

Q34186021-06FD1800-647A-4DD7-9931-5F5DBE9DC1B8

P932

Q34186021-B61B6B74-3542-49B3-87D9-14709BE800BB

P356

JOURNAL.PONE.0032838

P1433

P1476

Overexpression of ZEB2 in peri ...... n of hepatocellular carcinoma.

@en

P2093

Jia-Bin Lu

http://www.w3.org/2001/XMLSchema#string

Jie-Wei Chen

http://www.w3.org/2001/XMLSchema#string

Jing-Hui Hou

http://www.w3.org/2001/XMLSchema#string

Jing-Ping Yun

http://www.w3.org/2001/XMLSchema#string

Mu-Yan Cai

http://www.w3.org/2001/XMLSchema#string

Rong-Zhen Luo

http://www.w3.org/2001/XMLSchema#string

Xiao-Qing Pei

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple tumor suppressor pathways negatively regulate telomerase

Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells

Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins

Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway

TGFbeta in Cancer

Cancer statistics, 2007

The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion

SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes.

New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites.

SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation

P304

e32838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0032838

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221680445

http://www.w3.org/2001/XMLSchema#string

P698

22393452

http://www.w3.org/2001/XMLSchema#string

P921

P932

3290607

http://www.w3.org/2001/XMLSchema#string